Tissue-plasminogen activator effects on the phenotype of splenic myeloid cells in acute inflammation. [PDF]
Seillier C+7 more
europepmc +1 more source
Abstract Objective To evaluate whether intracameral tissue plasminogen activator (tPA) injection is effective in regulating posterior capsular opacification (PCO), fibrin formation and intraocular pressure (IOP) after cataract surgery. Animal Studied Prospective study involving 30 eyes of 21 dogs that underwent phacoemulsification.
Kyulee Kim+2 more
wiley +1 more source
Intravitreal tissue plasminogen activator in submacular haemorrhage
Singh Preetam+5 more
doaj
Catheter-Directed Arterial Thrombolysis with a Low-Dose Recombinant Tissue Plasminogen Activator Regimen for Acute Lower Limb Ischemia-Results of the First Regional Registry of Acute Limb Ischemia in Romania. [PDF]
Barac S+7 more
europepmc +1 more source
Intracellular distribution of tissue-type plasminogen activator in human melanoma cells.
Tetsuhiro Sakai+5 more
openalex +2 more sources
Differences in Acute Expression of Matrix Metalloproteinases-9, 3, and 2 Related to the Duration of Brain Ischemia and Tissue Plasminogen Activator Treatment in Experimental Stroke. [PDF]
Wang D+4 more
europepmc +1 more source
Abstract figure legend Illustration of cellular and molecular cross‐talk in atrial fibrillation. Left: a schematic of cardiac tissue showing cardiomyocytes, fibroblasts, adipocytes, inflammatory cells and the coagulation system. Right: direct and indirect cross‐talk between different cell types, with the impact of direct cross‐talk on action potential (
Zhenyu Dong+2 more
wiley +1 more source
Effects of Combination Therapy with Intravitreal Ranibizumab and Tissue Plasminogen Activator for Neovascular Age-Related Macular Degeneration. [PDF]
Ando M+11 more
europepmc +1 more source
Alleviating Recombinant Tissue Plasminogen Activator-induced Hemorrhagic Transformation in Ischemic Stroke via Targeted Delivery of a Ferroptosis Inhibitor. [PDF]
Geng YQ+13 more
europepmc +1 more source